PROVECTUS BIOPHARMACEUTICALS, INC. Annual Depreciation in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Provectus Biopharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2010 to 2023.
  • Provectus Biopharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $2.23K, a 0.05% increase year-over-year.
  • Provectus Biopharmaceuticals, Inc. annual Depreciation for 2023 was $8.92K, a 18.1% decline from 2022.
  • Provectus Biopharmaceuticals, Inc. annual Depreciation for 2022 was $10.9K, a 15.3% decline from 2021.
  • Provectus Biopharmaceuticals, Inc. annual Depreciation for 2021 was $12.9K, a 5.98% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.92K -$1.97K -18.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $10.9K -$1.97K -15.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $12.9K -$818 -5.98% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $13.7K -$409 -2.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $14.1K -$1 -0.01% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $14.1K -$1.77K -11.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $15.9K +$2.75K +21% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $13.1K -$53 -0.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-23
2015 $13.2K +$4.63K +54.3% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $8.53K +$2.17K +34% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-31
2013 $6.37K +$199 +3.23% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
2012 $6.17K -$1.19K -16.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $7.36K -$1.5K -16.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
2010 $8.86K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.